BeiGene Company Insiders

BGNE Stock  USD 189.77  4.79  2.46%   
BeiGene's insiders are aggressively selling. The analysis of the overall insider sentiment regarding BeiGene suggests that all insiders are panicking. BeiGene employs about 10.6 K people. The company is managed by 16 executives with a total tenure of roughly 28 years, averaging almost 1.0 years of service per executive, having 662.5 employees per reported executive.
Xiaodong Wang  Chairman
CoChairman CoFounder
John Oyler  Chairman
Chairman of the Board, CEO, Founder

BeiGene's Insider Buying Vs Selling

0

 
Selling
 
Buying

Latest Trades

2024-10-08John OylerDisposed 6175 @ 232.22View
2024-09-30Chan Henry LeeDisposed 1202 @ 237.1View
2024-09-27Lai WangDisposed 5000 @ 220.35View
2024-09-19Xiaobin WuDisposed 4500 @ 200.14View
2024-09-17Xiaobin WuDisposed 500 @ 200View
2024-09-03Xiaobin WuDisposed 5556 @ 189.65View
2024-07-30Chan Henry LeeDisposed 834 @ 160.57View
2024-07-01Julia Aijun WangDisposed 472 @ 143.9View
2024-06-24Julia Aijun WangDisposed 899 @ 155.66View
2024-04-10John OylerDisposed 26716 @ 148.89View
2024-03-12John OylerDisposed 37668 @ 164.02View
2024-02-29Julia Aijun WangDisposed 397 @ 167.08View
Monitoring BeiGene's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BeiGene. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For information on how to trade BeiGene Stock refer to our How to Trade BeiGene Stock guide.

BeiGene's Workforce Through the Years

Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with BeiGene's future performance. Based on our forecasts, it is anticipated that BeiGene will maintain a workforce of about 10600 employees by December 2024.
 
Yuan Drop
 
Covid

BeiGene Management Team Effectiveness

The company has return on total asset (ROA) of (0.0958) % which means that it has lost $0.0958 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2322) %, meaning that it created substantial loss on money invested by shareholders. BeiGene's management efficiency ratios could be used to measure how well BeiGene manages its routine affairs as well as how well it operates its assets and liabilities. As of November 22, 2024, Return On Tangible Assets is expected to decline to -0.16. In addition to that, Return On Capital Employed is expected to decline to -0.32. At present, BeiGene's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 37.5 M, whereas Other Assets are forecasted to decline to 1.90.
As of November 22, 2024, Common Stock Shares Outstanding is expected to decline to about 72.1 M. The current year's Net Loss is expected to grow to about (1.7 B)

BeiGene Workforce Comparison

BeiGene is number one stock in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 24,721. BeiGene totals roughly 10,600 in number of employees claiming about 43% of equities under Health Care industry.
The company has Profit Margin (PM) of (0.25) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.14) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.14.

BeiGene Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific BeiGene insiders, such as employees or executives, is commonly permitted as long as it does not rely on BeiGene's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, BeiGene insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Yuan Drop
 
Covid
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2024-09-01
0.3077
4
13
 364,923 
 319,658 
2024-06-01
0.8158
31
38
 4,354,727 
 64,442 
2024-03-01
0.0556
1
18
 27,794 
 147,094 
2023-06-01
1.0357
29
28
 4,937,452 
 4,361,788 
2023-03-01
0.0435
1
23
 67,635 
 1,030,922 
2022-09-01
0.0526
2
38
 15,600 
 98,486 
2022-06-01
1.4375
23
16
 9,156,654 
 1,048,091 
2021-12-01
0.1039
8
77
 78,557 
 141,237 
2021-09-01
0.0433
9
208
 207,903 
 1,706,030 
2021-06-01
0.5806
36
62
 2,773,385 
 3,301,137 
2021-03-01
0.1667
5
30
 18,500 
 460,154 
2020-12-01
0.2069
12
58
 3,559,739 
 8,714,572 
2020-09-01
0.076
19
250
 44,610,223 
 1,047,613 
2020-06-01
0.2969
19
64
 4,292,255 
 246,514 
2020-03-01
0.2727
3
11
 24,970 
 47,000 
2019-12-01
0.1525
9
59
 596,650 
 591,773 
2019-09-01
0.3636
8
22
 287,420 
 71,625 
2019-06-01
1.1304
26
23
 6,423,288 
 845,763 
2019-03-01
0.0625
2
32
 35,910 
 69,077 
2018-12-01
0.0864
7
81
 102,000 
 985,746 
2018-09-01
0.1818
2
11
 5,814,100 
 16,679 
2018-06-01
13.0
26
2
 7,104,073 
 5,000,000 
2018-03-01
0.1064
5
47
 2,025,198 
 944,865 
2017-12-01
0.0714
3
42
 9,602 
 491,501 
2017-09-01
0.375
6
16
 2,786,056 
 454,077 
2017-06-01
0.8
12
15
 6,596,420 
 220,981 
2016-12-01
6.0
6
1
 7,203,925 
 93,750 
2016-09-01
0.5833
7
12
 5,510,000 
 442,310 
2016-03-01
0.8846
23
26
 213,902,954 
 135,561,007 

BeiGene Notable Stakeholders

A BeiGene stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as BeiGene often face trade-offs trying to please all of them. BeiGene's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting BeiGene's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Xiaodong WangCoChairman CoFounderProfile
John OylerChairman of the Board, CEO, FounderProfile
Xiaobin WuPresident COOProfile
Aaron RosenbergCFO OfficerProfile
Chan LeeGeneral VPProfile
Titus BallVP OfficerProfile
Mi ZhouDirector RelationsProfile
Liza HeapesHead RelationsProfile
Wang LaiGlobal RDProfile
Kevin MannixVP RelationsProfile
Julia WangExecutive OfficerProfile
Jason RadfordSenior DevelopmentProfile
Yang JiChief OfficerProfile
Daniel MallerVP AccountingProfile
Diana FrancisVP ComplianceProfile
Yan QiSenior ChinaProfile

About BeiGene Management Performance

The success or failure of an entity such as BeiGene often depends on how effective the management is. BeiGene management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of BeiGene management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the BeiGene management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.15)(0.16)
Return On Capital Employed(0.30)(0.32)
Return On Assets(0.15)(0.16)
Return On Equity(0.25)(0.26)
Please note, the presentation of BeiGene's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, BeiGene's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of BeiGene's management manipulating its earnings.

BeiGene Workforce Analysis

Traditionally, organizations such as BeiGene use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare BeiGene within its industry.

BeiGene Manpower Efficiency

Return on BeiGene Manpower

Revenue Per Employee232K
Revenue Per Executive153.7M
Net Loss Per Employee83.2K
Net Loss Per Executive55.1M
Working Capital Per Employee225.8K
Working Capital Per Executive149.6M

Complementary Tools for BeiGene Stock analysis

When running BeiGene's price analysis, check to measure BeiGene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BeiGene is operating at the current time. Most of BeiGene's value examination focuses on studying past and present price action to predict the probability of BeiGene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BeiGene's price. Additionally, you may evaluate how the addition of BeiGene to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Stocks Directory
Find actively traded stocks across global markets
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Money Managers
Screen money managers from public funds and ETFs managed around the world
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges